Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 6.1B | 6.3B | 6.8B | 6.5B |
Cost of revenue | 4.0B | 4.1B | 4.6B | 4.3B |
Gross profit | 2.2B | 2.2B | 2.2B | 2.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 381M | 367M | 104M | 330M |
Other operating expenses | -8M | -5M | 228M | -5M |
Operating income | 342M | 402M | 419M | 455M |
Non operating interest income | ||||
Income | 4M | 12M | 2M | 6M |
Expense | 13M | 10M | -5M | 12M |
Other income expense | — | — | — | — |
Pretax income | 334M | 405M | 420M | 451M |
Tax provision | 82M | 102M | 105M | 112M |
Net income | 252M | 303M | 315M | 339M |
Basic EPS | 2.0 | 2.5 | — | 2.7 |
Diluted EPS | 2.0 | 2.5 | — | 2.7 |
Basic average shares | 118.8M | 118.8M | — | 118.2M |
Diluted average shares | 118.8M | 118.8M | — | 118.7M |
EBITDA | 571M | 640M | 626M | 669M |
Net income from continuing op. | 252M | 303M | 315M | 339M |
Minority interests | -12M | -12M | -19M | -15M |
Preferred stock dividends | 0 | 0 | 0 | 0 |